Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2018

01-10-2018 | Original Article

Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis

Authors: Meng Zhu, Ning Zhang, Xinlan Lu, Shuixiang He

Published in: Digestive Diseases and Sciences | Issue 10/2018

Login to get access

Abstract

Background

MicroRNAs are classes of endogenous noncoding RNAs that play a substantial role in tumor processes through regulating the targets at posttranscriptional level. However, little is known about the upstream transcription regulatory mechanism although it is a prerequisite for investigation of its aberrant expression and function.

Aims

This report evaluates miR-106a’s direct transcriptional factor from upstream level to in depth elucidate their communication in gastric cancer development.

Methods

Gastric cancer tissues were collected to analyze the miR-106a expression using real-time PCR methods. The combination of Kruppel (or Krüppel)-like factor 4 (KLF4) to miR-106a promoter was testified through bioinformatics followed by construction of luciferase reporter plasmid and chromatin immunoprecipitation assay. Functional experiments and mouse models for evaluating cell growth and metastasis were conducted to observe the biological effect of KLF4 on miR-106a. The interplay between KLF4 and miR-106a was tested with Wnt activator and confirmed in clinical specimens.

Results

The up-regulated miR-106a linked to gastric cancer metastasis and epithelial–mesenchymal transition. UCSC and JASPAR predicted the promoter sequence of miR-106a and its binding site with transcriptional factor KLF4. Construction of reporter gene further verified their direct combination at upstream level. Moreover, the inhibitory effect of KLF4 on the phenotype of gastric cancer cells could be restored by miR-106a. CHIR-induced experiment and clinical specimens confirmed the negative regulation of KLF4 on miR-106a.

Conclusions

Our findings provide novel direct insights into molecular mechanisms for interaction of KLF4 and miR-106a at upstream level and new ways for clinical application of KLF4–miR-106a axis in advanced gastric cancer metastasis.
Appendix
Available only for authorised users
Literature
2.
go back to reference Molina-Castro S, Pereira-Marques J, Figueiredo C, et al. Gastric cancer: basic aspects. Helicobacter. 2017;22:1.CrossRef Molina-Castro S, Pereira-Marques J, Figueiredo C, et al. Gastric cancer: basic aspects. Helicobacter. 2017;22:1.CrossRef
3.
go back to reference He Z, Zhao TT, Xu HM, et al. Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials. Oncotarget. 2017;8:81125–81136.PubMedPubMedCentral He Z, Zhao TT, Xu HM, et al. Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials. Oncotarget. 2017;8:81125–81136.PubMedPubMedCentral
4.
go back to reference Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38:485–491.CrossRefPubMed Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38:485–491.CrossRefPubMed
5.
go back to reference Shi Z, Wei Q, She J. microRNAs in gastric cancer metastasis. Crit Rev Eukaryot Gene Expr. 2014;24:39–53.CrossRefPubMed Shi Z, Wei Q, She J. microRNAs in gastric cancer metastasis. Crit Rev Eukaryot Gene Expr. 2014;24:39–53.CrossRefPubMed
6.
go back to reference Zhao X, Li X, Yuan H. microRNAs in gastric cancer invasion and metastasis. Front Biosci (Landmark Ed). 2013;18:803–810.CrossRef Zhao X, Li X, Yuan H. microRNAs in gastric cancer invasion and metastasis. Front Biosci (Landmark Ed). 2013;18:803–810.CrossRef
7.
go back to reference Zheng Y, Liu L, Shukla GC. A comprehensive review of web-based non-coding RNA resources for cancer research. Cancer Lett. 2017;407:1–8.CrossRefPubMed Zheng Y, Liu L, Shukla GC. A comprehensive review of web-based non-coding RNA resources for cancer research. Cancer Lett. 2017;407:1–8.CrossRefPubMed
8.
11.
go back to reference Xiao B, Guo J, Miao Y, et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta. 2009;400:97–102.CrossRefPubMed Xiao B, Guo J, Miao Y, et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta. 2009;400:97–102.CrossRefPubMed
12.
go back to reference Wang Z, Liu M, Zhu H, et al. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog. 2013;52:634–646.CrossRefPubMed Wang Z, Liu M, Zhu H, et al. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog. 2013;52:634–646.CrossRefPubMed
13.
14.
go back to reference Zhang N, Zhang J, Shuai L, et al. Kruppel-like factor 4 negatively regulates beta-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer. Int J Oncol. 2012;40:2038–2048.PubMed Zhang N, Zhang J, Shuai L, et al. Kruppel-like factor 4 negatively regulates beta-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer. Int J Oncol. 2012;40:2038–2048.PubMed
15.
go back to reference Segura MF, Jubierre L, Li S, et al. Kruppel-like factor 4 (KLF4) regulates the miR-183 ~ 96 ~ 182 cluster under physiologic and pathologic conditions. Oncotarget. 2017;8:26298–26311.CrossRefPubMedPubMedCentral Segura MF, Jubierre L, Li S, et al. Kruppel-like factor 4 (KLF4) regulates the miR-183 ~ 96 ~ 182 cluster under physiologic and pathologic conditions. Oncotarget. 2017;8:26298–26311.CrossRefPubMedPubMedCentral
16.
17.
go back to reference Calin GA, Croce CM. microRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66:7390–7394.CrossRefPubMed Calin GA, Croce CM. microRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66:7390–7394.CrossRefPubMed
18.
go back to reference Iorio MV, Croce CM. microRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143–159.CrossRefPubMedPubMedCentral Iorio MV, Croce CM. microRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143–159.CrossRefPubMedPubMedCentral
19.
go back to reference Li P, Xu Q, Zhang D, et al. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett. 2014;588:705–712.CrossRefPubMed Li P, Xu Q, Zhang D, et al. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett. 2014;588:705–712.CrossRefPubMed
20.
go back to reference Liu Z, Gersbach E, Zhang X, et al. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma. Mol Cancer Res. 2013;11:1314–1325.CrossRefPubMedPubMedCentral Liu Z, Gersbach E, Zhang X, et al. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma. Mol Cancer Res. 2013;11:1314–1325.CrossRefPubMedPubMedCentral
21.
go back to reference Wang Z, Wang B, Shi Y, et al. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. 2015;34:1407–1419.CrossRefPubMed Wang Z, Wang B, Shi Y, et al. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. 2015;34:1407–1419.CrossRefPubMed
22.
go back to reference Varghese VK, Shukla V, Kabekkodu SP, et al. DNA methylation regulated microRNAs in human cervical cancer. Mol Carcinog. 2018;57:370–382.CrossRefPubMed Varghese VK, Shukla V, Kabekkodu SP, et al. DNA methylation regulated microRNAs in human cervical cancer. Mol Carcinog. 2018;57:370–382.CrossRefPubMed
23.
go back to reference Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cancer. Cell Cycle. 2008;7:2643–2646.CrossRefPubMed Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cancer. Cell Cycle. 2008;7:2643–2646.CrossRefPubMed
24.
go back to reference Mao L, Zhang Y, Deng X, et al. Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. Am J Cancer Res. 2015;5:1939–1953.PubMedPubMedCentral Mao L, Zhang Y, Deng X, et al. Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. Am J Cancer Res. 2015;5:1939–1953.PubMedPubMedCentral
26.
go back to reference Church VA, Pressman S, Isaji M, et al. Microprocessor recruitment to elongating RNA polymerase II Is required for differential expression of microRNAs. Cell Rep. 2017;20:3123–3134.CrossRefPubMedPubMedCentral Church VA, Pressman S, Isaji M, et al. Microprocessor recruitment to elongating RNA polymerase II Is required for differential expression of microRNAs. Cell Rep. 2017;20:3123–3134.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Wong ES, Schmitt BM, Kazachenka A, et al. Interplay of cis and trans mechanisms driving transcription factor binding and gene expression evolution. Nat Commun. 2017;8:1092.CrossRefPubMedPubMedCentral Wong ES, Schmitt BM, Kazachenka A, et al. Interplay of cis and trans mechanisms driving transcription factor binding and gene expression evolution. Nat Commun. 2017;8:1092.CrossRefPubMedPubMedCentral
29.
go back to reference Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem. 1996;271:20009–20017.CrossRefPubMedPubMedCentral Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem. 1996;271:20009–20017.CrossRefPubMedPubMedCentral
30.
go back to reference Li J, Zheng H, Yu F, et al. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis. Carcinogenesis. 2012;33:1239–1246.CrossRefPubMedPubMedCentral Li J, Zheng H, Yu F, et al. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis. Carcinogenesis. 2012;33:1239–1246.CrossRefPubMedPubMedCentral
32.
go back to reference Hsu LS, Chan CP, Chen CJ, et al. Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma. Med Oncol. 2013;30:632.CrossRefPubMed Hsu LS, Chan CP, Chen CJ, et al. Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma. Med Oncol. 2013;30:632.CrossRefPubMed
33.
go back to reference Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005;65:2746–2754.CrossRefPubMed Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005;65:2746–2754.CrossRefPubMed
34.
go back to reference Ai Z, Shao J, Wu Y, et al. CHIR99021 enhances Klf4 expression through beta-catenin signaling and miR-7a regulation in J1 mouse embryonic stem cells. PLoS One. 2016;11:e0150936.CrossRefPubMedPubMedCentral Ai Z, Shao J, Wu Y, et al. CHIR99021 enhances Klf4 expression through beta-catenin signaling and miR-7a regulation in J1 mouse embryonic stem cells. PLoS One. 2016;11:e0150936.CrossRefPubMedPubMedCentral
Metadata
Title
Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis
Authors
Meng Zhu
Ning Zhang
Xinlan Lu
Shuixiang He
Publication date
01-10-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5143-z

Other articles of this Issue 10/2018

Digestive Diseases and Sciences 10/2018 Go to the issue